CRISPR to the RESCUE: Gene Editing Technology Gets More Versatile
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
News
The latest news and updates about NYSCF and our collaborators
323 Results
Clear Filters
NYSCF Collaboration Finds Possible Mechanism Behind Tired Brain Cells in Progressive MS
The Context: In multiple sclerosis (MS), brain cells degenerate and malfunction, leaving patients with symptoms such as numbness, weakness, vision loss, tremor, fatigue, and cognitive impairment....
In Determining Disgust vs. Attraction, Timing is Everything
The Context: To survive, animals learn from their surroundings. Forming associations with sights, sounds, and smells helps create a bank of information and behaviors that can...
On the Same Wavelength: Michael Yartsev Discovers that Bats’ Brains Sync When They Socialize
The Context: When humans talk to each other, there is a correlation in our brain activity—in some areas, it syncs up. But human studies have been...
NYSCF Innovators Forge New Connections at Annual Retreat
What one word would our Innovators use to describe the NYSCF community? “Family,” said NYSCF – Robertson Neuroscience Investigator and Stanford University Assistant Professor of Neurobiology...
Exploring the Promise of Regenerative Medicine at “Stem Cells in the City”
The key to fixing many devastating diseases and injuries could very well lie in regenerative medicine. The secret? Stem cell research. At NYSCF’s recent event, “Stem...
A New Frontier for Understanding Fatty Liver Disease
The Context: Fatty liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic stereohepatitis (NASH), and Wolman disease are especially difficult to study and treat due...
NYSCF – Druckenmiller Fellows Gather in New York to Welcome New Class and Reconnect
The NYSCF – Druckenmiller Fellowship Program supports the most talented postdoctoral scientists at critical junctures in their careers who are in the pursuit of innovative and...
CRISPR Gets an Upgrade Thanks to “Jumping Genes”
The Context: CRISPR is a powerful, ‘word-processor’-like tool for editing DNA, but currently it is much easier to eliminate undesired sequences than it is to accurately...
NYSCF Collaboration Discovers New Role for Metabolism in Pluripotency
The Context: What makes stem cells special is their ability to turn into other cell types in the body (a characteristic called “pluripotency”). Our understanding of...
NYSCF Collaboration Identifies Promising Drug for Treating Most Common Form of Macular Degeneration
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
Gene Editing: The Science, Ethics, and Promise of a Revolutionary Technology
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
Inspiring the Next Generation of Scientists: NYSCF Hosts Second Annual Family Stem Cell Day
“Who thinks I can power this lightbulb with just the electricity from my finger?” Dr. Cecile Terrenoire asks a crowded room of eager students. About half...
Protecting Premature Babies from Brain Damage
The Context: It is estimated that 15 million babies are born prematurely each year, and a common premature birth complication is low oxygen levels. We know...
NYSCF Hosts Launch of Jamie Metzl’s New Book: “Hacking Darwin: Genetic Engineering and the Future of Humanity”
“After 3.8 billion years of evolving by Darwinian principles, we are turning a corner and taking more control over all biology, including our own,” explained Jamie...
Speak Your Mind: Edward Chang Pioneers Device That Translates Brain Activity Into Speech
The Context: Patients suffering from stroke, paralysis, ALS, Parkinson’s, and many other conditions are often left with impaired speaking and gesturing abilities, and there are few...
Stem Cells, Alzheimer’s, and Caregiving: Susan L. Solomon Guests Stars on the “Thank You Dan and Alex” Podcast
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
A Gut Feeling: Zachary Knight Discovers That Thirst is Controlled by Signals in the Gastrointestinal Tract
The Context: The brain has “thirst neurons” that help us know when we need water and when we don’t. But how these neurons receive information from...
Shifting Paradigms in Research and Treatment of Women’s Reproductive Cancers
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
NYSCF–Druckenmiller Alumna Maria Themeli is Paving the Way to Democratize Access to Cancer Treatments
Maria Themeli, MD, PhD, believes that everyone, no matter their financial situation, should have access to effective cancer treatments. Because of this, she is working to...
Dr. Feng Zhang Launches New CRISPR Biotech to Create Better Diagnostic Tools
NYSCF – Robertson Stem Cell Investigator, CRISPR pioneer, and MIT Professor of Brain and Cognitive Sciences and Biological Engineering Dr. Feng Zhang and his collaborators have...
Scientists Reconnect at Inaugural NYSCF – Robertson Investigator Alumni Meetings
Building a strong community of researchers committed to advancing cutting-edge science is critical for getting treatments and cures to patients as quickly as possible. Because of...
Supporting 30 Million Patients on Rare Disease Day
“At the current rate of therapeutic development for rare diseases, it will be 2000 years before doctors won’t have to say to patients, ‘There’s nothing more...
The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...